ResMed Inc.
RSMDF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $5 | $5 | $4 | $4 |
| % Growth | 9.8% | 10.9% | 18% | – |
| Cost of Goods Sold | $2 | $2 | $2 | $2 |
| Gross Profit | $3 | $3 | $2 | $2 |
| % Margin | 59.4% | 56.7% | 55.8% | 56.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | $2 | $1 | $1 | $1 |
| % Margin | 32.7% | 28.2% | 26.8% | 28% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $2 | $1 | $1 | $1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $1 | $1 | $1 | $1 |
| % Margin | 27.2% | 21.8% | 21.3% | 21.8% |
| EPS | 9.55 | 6.94 | 6.12 | 5.34 |
| % Growth | 37.6% | 13.4% | 14.6% | – |
| EPS Diluted | 9.51 | 6.92 | 6.09 | 5.3 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $2 | $2 | $1 | $1 |
| % Margin | 37.2% | 32.7% | 32.2% | 32.9% |